Interested specialists from the world of BioTech and MedTech were presented the following topics:
• The most critical factors in the AI application development in the BioTech sector;
• Competitiveness of the European BioTech companies (which implement AI) in comparison to organizations from the USA and China;
• The benefits from the growing amount of data “produced” by the healthcare system during patient diagnostics;
• Fears and concerns over AI potentially replacing scientists in labs or R&D departments;
At this point, we’d like to thank all the panelists – Katarzyna Kolasa, PhD, Richard Fox, Pawel Kuśmierowski, and Tomasz Pilewicz, PhD for the heated discussion on each of these topics (and a few more!). It was a pleasure to talk with you and collectively forecast the future of AI and BioTech tandem.